Welcome to our dedicated page for WW Grainger SEC filings (Ticker: GWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
WW Grainger’s dual model—High-Touch Solutions branches and the fast-growing Zoro / MonotaRO online marketplaces—makes every SEC document a window into how industrial distribution is evolving. If you’re searching for “WW Grainger insider trading Form 4 transactions” or need the latest “Grainger quarterly earnings report 10-Q filing,” this page gathers it all in one place and keeps it current as soon as EDGAR posts.
Stock Titan’s AI reads each filing the moment it lands, then delivers plain-English answers to questions professionals actually ask: How did Endless Assortment margins shift? What inventory levels sit on the balance sheet? Which executives purchased shares last week? Whether you open the “WW Grainger annual report 10-K simplified” summary, the “Grainger proxy statement executive compensation” breakdown, or an “WW Grainger 8-K material events explained” alert, our platform removes the technical clutter.
Key resources you’ll find here include:
- Real-time WW Grainger Form 4 insider transactions with instant AI annotations.
- Concise takeaways from every Grainger earnings report filing analysis (10-Q) showing segment sales and inventory turns.
- Side-by-side redlines that make understanding Grainger SEC documents with AI effortless.
Professionals rely on these insights to monitor supply-chain exposures, track digital revenue momentum, and spot executive stock moves before the market reacts. Explore the filings below—each one explained simply, updated in real time, and ready to inform your next decision.
Playboy, Inc. (Nasdaq: PLBY) has filed a Rule 424(b)(5) prospectus supplement to reactivate its at-the-market (ATM) equity program. Under an amended Sales Agreement with Roth Capital Partners dated 8 Aug 2024 and amended 18 Jul 2025, the company may sell up to $15 million in common stock (par $0.0001) from time to time. No shares have been sold under the prior August 2024 supplement, so the full $15 million capacity is now available.
Shares will be offered at prevailing market prices; Roth will receive a 3.0 % commission and is deemed an underwriter. At the 17 Jul 2025 closing price of $1.83, the program could issue roughly 8.4 million new shares, expanding pro-forma outstanding shares to ≈102.4 million (vs. 93.9 million at 31 Mar 2025) and implying up to ~9 % dilution.
Use of proceeds: working capital, general corporate purposes, possible debt repayment or acquisitions. Net tangible book value was -$1.97/share as of 31 Mar 2025; the illustrative financing lifts this to -$1.67/share, yielding immediate dilution of $3.45/share.
Key risks highlighted include continued Nasdaq listing compliance (price and board independence), further equity dilution from options/RSUs, and broad management discretion over proceeds. The supplement incorporates the company’s 2024 Form 10-K and Q1-25 Form 10-Q by reference.
The Vanguard Group filed Amendment No. 2 to Schedule 13G disclosing a passive position in Universal Technical Institute (UTI) as of 30 Jun 2025.
- Beneficial ownership: 3,315,026 common shares.
- Represents 6.09 % of the outstanding class, exceeding the 5 % reporting threshold.
- Voting authority: 0 shares sole; 60,294 shares shared.
- Dispositive authority: 3,209,454 shares sole; 105,572 shares shared.
- Filer status: Investment Adviser (IA) filing under Rule 13d-1(b).
The firm certifies the stake is held in the ordinary course of business and not for the purpose of influencing control. The filing is signed by Ashley Grim, Head of Global Fund Administration, on 29 Jul 2025.